{"id":4380,"date":"2025-06-05T23:02:33","date_gmt":"2025-06-05T23:02:33","guid":{"rendered":"https:\/\/mailitics.com\/index.php\/2025\/06\/05\/glp-1-drugs-low-but-elevated-risk-of-age-related-macular-degeneration\/"},"modified":"2025-06-05T23:02:33","modified_gmt":"2025-06-05T23:02:33","slug":"glp-1-drugs-low-but-elevated-risk-of-age-related-macular-degeneration","status":"publish","type":"post","link":"https:\/\/mailitics.com\/index.php\/2025\/06\/05\/glp-1-drugs-low-but-elevated-risk-of-age-related-macular-degeneration\/","title":{"rendered":"GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds"},"content":{"rendered":"

GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
\n \t

\n
<\/BR>
\n
\n \t

\n
<\/BR><\/p>\n

\n

People with diabetes who were taking GLP-1 drugs had a low but elevated risk of an age-related eye disease that can sometimes lead to blindness, a new observational study concludes, adding to a short list of concerns about eye health in people taking the powerful medications.<\/p>\n

The research, published Thursday in JAMA Ophthalmology<\/a>, found that after one year, more than twice as many people on GLP-1 drugs developed neovascular age-related macular degeneration compared to similar people who were not taking the drugs. The risk was 0.2% in people taking GLP-1s and 0.1% in those who didn\u2019t. Participants, drawn from health records of nearly 140,000 patients in Canada, were matched for socioeconomic status and a long list of conditions in addition to diabetes.<\/p>\n

Read the rest\u2026<\/a><\/p>\n<\/div>\n

\t

\n
<\/BR>
\n Elizabeth Cooney
\n \t

\n
<\/BR>
\nGo to statnews<\/a>
\n \t

\n
<\/BR><\/p>\n","protected":false},"excerpt":{"rendered":"

GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds People with diabetes who were taking GLP-1 drugs had a low but elevated risk of an age-related eye disease that can sometimes lead to blindness, a new observational study concludes, adding to a short list of concerns about eye health in […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2154,2362,2868,1428,2282,2176,2155],"tags":[2150],"class_list":["post-4380","post","type-post","status-publish","format-standard","hentry","category-biotechnology","category-chronic-disease","category-diabetes","category-health","category-obesity","category-pharma","category-pharmaceuticals","tag-statnews"],"_links":{"self":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/4380"}],"collection":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/comments?post=4380"}],"version-history":[{"count":0,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/4380\/revisions"}],"wp:attachment":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/media?parent=4380"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/categories?post=4380"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/tags?post=4380"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}